OTCMKTS:CSRMY Consort Medical (CSRMY) Stock Price, News & Analysis → His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad) Free CSRMY Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$10.80▼$10.8050-Day Range N/A52-Week Range$13.25▼$16.65Volume92 shsAverage Volume190 shsMarket Capitalization$532.22 millionP/E Ratio12.56Dividend Yield1.57%Price TargetN/A Stock AnalysisStock Analysis Get Consort Medical alerts: Email Address Ad Investing DailyHis win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. About Consort Medical Stock (OTCMKTS:CSRMY)Consort Medical plc operates as a one-stop developer and manufacturer of drugs and premium drug delivery devices. It operates through two divisions, Bespak and Aesica. The company provides various life improving treatments to patients across worldwide through the design, development, and manufacture of medical devices for inhaled, injectable, nasal, and ocular drug delivery, as well as point of care diagnostics products. It also develops, formulates, and manufactures active pharmaceutical ingredients and finished dose drugs. Consort Medical plc was incorporated in 1946 and is based in Hemel Hempstead, the United Kingdom.Read More Ad Investing DailyHis win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. CSRMY Stock News HeadlinesMay 24, 2023 | usatoday.comQueen Camilla's complicated love story with King Charles and changing public perceptionMay 7, 2023 | usatoday.comWhy is Camilla being crowned queen? King Charles' wife's role at the coronation, explainedApril 29, 2024 | Investing Daily (Ad)His win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.April 29, 2023 | dailymail.co.ukCamilla waxes regal! Madame Tussauds unveils a waxwork of the Queen Consort ahead of CoronationApril 6, 2023 | usatoday.comKing Charles, Camilla pose for new photo ahead of coronation, palace reveals invitation designApril 1, 2023 | abcnews.go.comCamilla wears tiara, nod to Queen Elizabeth II, in 1st state visit as Queen ConsortMarch 18, 2023 | dailymail.co.ukKing Charles and Queen Consort Camilla will sign his name on Coronation Champions certificatesMarch 18, 2023 | mirror.co.ukCamilla's huge change from Queen Consort title for Coronation in surprise moveApril 29, 2024 | Investing Daily (Ad)His win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.March 5, 2023 | dailymail.co.ukQueen Consort has two personal items valued by Antiques Roadshow expertsMarch 1, 2023 | nypost.comKing Charles ‘hammered’ Queen Elizabeth to drop Camilla’s consort titleMarch 1, 2023 | foxnews.comKing Charles ‘hammered away relentlessly’ at Queen Elizabeth to drop Camilla’s consort title, author claimsFebruary 27, 2023 | dailymail.co.ukCamilla will officially be known as the Queen rather than 'Queen Consort' after King's coronationFebruary 27, 2023 | nypost.comCamilla will be called Queen, not Queen Consort after King Charles’ coronation: reportFebruary 27, 2023 | mirror.co.ukCamilla 'to be called Queen after King's coronation as consort will be dropped'February 25, 2023 | dailymail.co.ukQueen Consort speaks out against censorship of Roald Dahl booksFebruary 25, 2023 | news.yahoo.comThe Queen Consort Urges Writers to be “Unimpeded” by Curbs on Freedom of Expression Amid Roald Dahl RowFebruary 16, 2023 | usatoday.comQueen Consort Camilla tests positive for COVID 'after suffering symptoms of a cold'January 15, 2023 | nypost.comCamilla’s pals defend Queen Consort against Harry’s ‘unfair’ slamsJanuary 11, 2023 | yahoo.comCamilla, Queen Consort, Is Reportedly "Astounded" by Prince Harry's Memoir AccusationsNovember 15, 2022 | dailymail.co.ukQueen Consort Camilla dons Bugle Horn brooch commissioned by the Rifles for Remembrance serviceOctober 17, 2022 | mirror.co.ukPalace plans to remove 'consort' from Camilla's title before Charles coronation - reportOctober 16, 2022 | uk.news.yahoo.comCamilla visits hospital in first solo engagement as Queen ConsortOctober 4, 2022 | uk.news.yahoo.comQueen Consort: What does Camilla's new title mean?October 2, 2022 | dailymail.co.ukCamilla, Queen ConsortSeptember 25, 2022 | yahoo.comQueen Consort Camilla Is Keeping a Private Home as an "Escape"See More Headlines Receive CSRMY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Consort Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Private Households Sub-IndustryN/A Current SymbolOTCMKTS:CSRMY Previous SymbolNASDAQ:CSRMY CUSIPN/A CIKN/A Webwww.consortmedical.com Phone44-14-4286-7920FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio12.56 Forward P/E Ratio13.33 P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.48 Current Ratio1.91 Quick Ratio0.50 Sales & Book Value Annual Sales$416.41 million Price / Sales1.28 Cash Flow$1.55 per share Price / Cash Flow6.95 Book Value$6.69 per share Price / Book1.61Miscellaneous Outstanding Shares49,280,000Free FloatN/AMarket Cap$532.22 million OptionableNot Optionable Beta0.01 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Jonathan M. Glenn (Age 49)CEO & Director Mr. Paul Hayes (Age 51)CFO & Exec. Director Mr. Andrew JacksonGroup Gen. Counsel & Company Sec.Ms. Lisa KingDirector of HRColin LeederGroup Financial ControllerKey CompetitorsOxford BiomedicaOTCMKTS:OXBDFAdociaOTCMKTS:ADOCYClinigen GroupOTCMKTS:CLIGFAbsciNASDAQ:ABSIIradimedNASDAQ:IRMDView All Competitors CSRMY Stock Analysis - Frequently Asked Questions Is Consort Medical a good dividend stock? Consort Medical (OTCMKTS:CSRMY) pays an annual dividend of $0.17 per share and currently has a dividend yield of 1.57%. The dividend payout ratio is 19.77%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CSRMY will have a dividend payout ratio of 19.54% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for CSRMY. This page (OTCMKTS:CSRMY) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyMan Who Predicted 2008: “This Will be Worse.”AltimetryHas Jeff Bezos Found the Next Nvidia?InvestorPlaceThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Consort Medical plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
